コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 f 6 mL/kg, PEEP set 2 cm H2O > Pflex); or d) high-frequency oscillatory ventilation.
2 s which enhance lung recruitment, especially high-frequency oscillatory ventilation.
3 l as extracorporeal membrane oxygenation and high-frequency oscillatory ventilation.
4 +/- 10.3 to 34.0 +/- 6.7 cm H2O, p < .05) on high-frequency oscillatory ventilation.
5 tion in acute lung injury when combined with high-frequency oscillatory ventilation.
6 ed outcomes for pediatric patients receiving high-frequency oscillatory ventilation.
7 onal ventilation preceding the initiation of high-frequency oscillatory ventilation.
8 uous distending pressure optimization during high-frequency oscillatory ventilation.
9 The rabbits were ventilated with high-frequency oscillatory ventilation.
10 monitoring right ventricular function during high-frequency oscillatory ventilation.
11 h acute respiratory distress syndrome during high-frequency oscillatory ventilation.
12 Tidal volumes are not uniformly small during high-frequency oscillatory ventilation.
13 s of measuring tidal volume during simulated high-frequency oscillatory ventilation.
14 pable of tracking lung volume changes during high-frequency oscillatory ventilation.
15 es and specific components of a protocol for high-frequency oscillatory ventilation.
16 patients with severe ARDS who are undergoing high-frequency oscillatory ventilation.
17 h group to receive intermittent mandatory or high-frequency oscillatory ventilation.
18 ume in a surfactant-deficient patient during high-frequency oscillatory ventilation.
19 e of CO2 values in pediatric patients during high-frequency oscillatory ventilation.
20 Percutaneous dilational tracheostomy during high-frequency oscillatory ventilation.
21 the percutaneous dilational tracheostomy or high-frequency oscillatory ventilation.
22 h acute respiratory distress syndrome during high-frequency oscillatory ventilation.
27 itude pressure oscillations delivered during high-frequency oscillatory ventilation; 2) to characteri
28 ents were submitted to three 1-hr periods of high-frequency oscillatory ventilation (+5, +10, +15) in
32 ventilation compared with animals receiving high-frequency oscillatory ventilation alone (253 +/- 16
34 was 75% (nine of 12), 80% (four of five) for high-frequency oscillatory ventilation alone, and 71% (f
35 pid improvement in arterial oxygenation than high-frequency oscillatory ventilation alone, in a pigle
38 verse events were similar between coenrolled high-frequency oscillatory ventilation and control patie
39 s treated with high-dose corticosteroids and high-frequency oscillatory ventilation and experienced a
40 infection and severe lung injury, the use of high-frequency oscillatory ventilation and extracorporea
41 the efficacy of rescue therapies, including high-frequency oscillatory ventilation and extracorporea
42 n to detect changes in lung mechanics during high-frequency oscillatory ventilation and has the poten
44 After lung injury, subjects were changed to high-frequency oscillatory ventilation and stabilized fo
46 aO2) were monitored during the transition to high-frequency oscillatory ventilation and throughout th
48 ure-volume relationship in infants receiving high-frequency oscillatory ventilation, and 2) to determ
49 o on to airway pressure release ventilation, high-frequency oscillatory ventilation, and computer-bas
50 patient variables affect tidal volume during high-frequency oscillatory ventilation; and b) measure t
54 ance and functional residual capacity during high-frequency oscillatory ventilation can be used to ad
55 drome, using high mean airway pressure under high-frequency oscillatory ventilation can worsen right
56 als that received 3 mL/kg of perflubron with high-frequency oscillatory ventilation compared with ani
59 ved a lung protective strategy (open lung or high-frequency oscillatory ventilation) exhibited more f
60 ntilation alone, and 71% (five of seven) for high-frequency oscillatory ventilation + extracorporeal
61 rs, prone positioning, inhaled nitric oxide, high-frequency oscillatory ventilation, extracorporeal m
63 ithm-controlled conventional ventilation vs. high-frequency oscillatory ventilation for adults with s
64 ion of current practice regarding the use of high-frequency oscillatory ventilation for pediatric hyp
65 r treatment of DAH after BMT and the role of high-frequency oscillatory ventilation for treatment of
71 ical benefit of heliox administration during high-frequency oscillatory ventilation has yet to be det
76 chanical lung recruitment techniques such as high-frequency oscillatory ventilation (HFOV) and partia
79 Acute lung injury models demonstrate that high-frequency oscillatory ventilation (HFOV) improves l
80 hat heliox would improve gas exchange during high-frequency oscillatory ventilation (HFOV) in a model
88 haled nitric oxide (iNO), prone positioning, high-frequency oscillatory ventilation (HFOV), and extra
89 onal study involving neonates suggested that high-frequency oscillatory ventilation (HFOV), as compar
90 ecreasing pulmonary vascular resistance with high-frequency oscillatory ventilation (HFOV), we develo
93 onal mechanical ventilation (CMV, n = 15) or high-frequency oscillatory ventilation (HFOV, n = 5).
94 onventional mechanical ventilation [CMV] vs. high-frequency oscillatory ventilation [HFOV]) on perflu
95 ommendation is strong against routine use of high-frequency oscillatory ventilation (high confidence
96 ute to ventilator-induced lung injury during high-frequency oscillatory ventilation in adults compare
98 There was a small but significant benefit of high-frequency oscillatory ventilation in terms of the p
100 ng the techniques of permissive hypercapnia, high frequency oscillatory ventilation, inhaled nitric o
102 al for ventilator-induced lung injury during high-frequency oscillatory ventilation is enhanced at fr
103 CT) showed a lung recruitment maneuver using high-frequency oscillatory ventilation just before surfa
104 The combination of low-dose perflubron with high-frequency oscillatory ventilation leads to more rap
106 ritical pulmonary status, patients requiring high-frequency oscillatory ventilation may especially be
107 cal basis for minimizing tidal volume during high-frequency oscillatory ventilation may not be approp
108 rflubron, the combination of perflubron with high-frequency oscillatory ventilation may permit effect
109 end-expiratory pressure) were randomized to high-frequency oscillatory ventilation (n = 75) or conve
110 idence for a clinical benefit of noninvasive high-frequency oscillatory ventilation (nHFOV) in preter
111 ric studies include endotracheal surfactant, high-frequency oscillatory ventilation, noninvasive vent
112 Measured tidal volumes were 23-225 mL during high-frequency oscillatory ventilation of the test lung.
113 probability of receiving early NMBA included high-frequency oscillatory ventilation on days 0-2 (odds
114 lment did not modify the treatment effect of high-frequency oscillatory ventilation on hospital morta
118 orticosteroids and then randomly assigned to high-frequency oscillatory ventilation or synchronized i
119 ne ventilation, extracorporeal life support, high-frequency oscillatory ventilation, or inhaled nitri
120 n preventive respiratory treatments include: high frequency oscillatory ventilation, permissive hyper
122 A lung volume recruitment strategy during high-frequency oscillatory ventilation produced improved
123 cal ventilation, notably in patients in whom high-frequency oscillatory ventilation produced less alv
124 euvers, airway pressure release ventilation, high-frequency oscillatory ventilation, prone positionin
127 with a high-amplitude (18 cm H2O) asymmetric high-frequency oscillatory ventilation square pressure w
128 The relative benefits of strategies such as high frequency oscillatory ventilation, surfactant repla
129 Syndrome Treated Early Trial, which compared high-frequency oscillatory ventilation to conventional v
131 OR, 11.0; 95% CI, 2.26-53.8 for the need for high-frequency oscillatory ventilation vs no respiratory
132 atory support (OR, 7.0; 95% CI, 1.3-37.1 for high-frequency oscillatory ventilation vs. no respirator
133 ion, conventional mechanical ventilation, or high-frequency oscillatory ventilation was continued for
135 determine whether infants treated with early high-frequency oscillatory ventilation were more likely
136 < .02) at 12, 24, and 48 hrs after starting high-frequency oscillatory ventilation were observed.
138 al comparing the safety and effectiveness of high-frequency oscillatory ventilation with conventional
139 h acute respiratory distress syndrome during high-frequency oscillatory ventilation with the Sensorme
142 s that infants who were randomly assigned to high-frequency oscillatory ventilation would have superi